Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

PreventiveMD vs Reset Solutions

PreventiveMD
Graded #53

Higher grade

vs+20.200000000000003
Reset Solutions
Graded #420

Lower grade

The verdict

PreventiveMD takes it — 76.4/100 to 56.2/100.

PreventiveMD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. PreventiveMD is a physician-guided telehealth platform for GLP-1 weight loss and peptide therapy, offering compounded semaglutide from $83/mo all-in and compounded tirzepatide from $97/mo all-in, plus brand…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePreventiveMD +40
85
45
Dose & formulationPreventiveMD +42
82
40
Clinical oversightPreventiveMD +4
82
78
Labs & monitoringReset Solutions +8
53
61
FulfillmentPreventiveMD +18
83
65
Contract termsEven
55
55
PreventiveMD · left barReset Solutions · right bar

The numbers

MetricPreventiveMDReset Solutions
WeighScore76.4/10056.2/100
GradeCC
Scorecard rank#53#420
Semaglutide$83/mo (as low as, term not published, all-in, compounded)Not disclosed
Tirzepatide$97/mo (as low as, term not published, all-in, compounded)Not disclosed
Coverage36 states1 state
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
PreventiveMD

Graded #53 · C

Strengths

  • Compounded semaglutide from $83/mo and tirzepatide from $97/mo, billed as one all-in monthly price
  • Brand Wegovy, Zepbound, and Foundayo (oral GLP-1) available on the same platform
  • US-licensed provider reviews requests within 24 hours — no video visit required
  • You aren't charged until a provider approves; checkout places an authorization hold only
  • LegitScript-certified; works exclusively with state-licensed US 503A compounding pharmacies

Where it loses points

  • Both figures are 'as low as' rates and the qualifying term is not published anywhere — the checkout is gated, so whether $97 is month-to-month or a multi-month prepay cannot be established before signing up
  • Brand-name routes are priced separately and do carry a fee: $49/mo membership plus medication from $149/mo for Foundayo and Wegovy, from $299/mo for Zepbound
  • No state count is published, and a state-variant waitlist implies some states are unserved
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
Reset Solutions

Graded #420 · C

Strengths

  • $99/mo program covers all medical visits, coaching, check-ins, and 3D body-composition testing
  • Medication priced separately starting at $70/month - combined from ~$169/mo, under the compounded-sema market median
  • Full refund if the doctor determines you are not a medical candidate
  • No long-term contract - cancel anytime; lower-cost maintenance plan once established
  • Local care team: in-person kickoff, dose adjustments over time, and app messaging

Where it loses points

  • Texas only - requires an in-person kickoff at its Shenandoah (The Woodlands) clinic
  • Medication form (compounded vs brand) is not stated in page copy; per-drug pricing not itemized
  • Tirzepatide cost not published - only 'starting at $70 per month' across medication options
  • Pharmacy partner not publicly named
  • No LegitScript certification displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard